Penn Davis McFarland’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.23M Hold
2,695
0.29% 42
2026
Q1
$2.48M Sell
2,695
-55
-2% -$55.8K 0.24% 48
2025
Q4
$2.96M Hold
2,750
0.28% 44
2025
Q3
$2.1M Hold
2,750
0.22% 48
2025
Q2
$2.14M Hold
2,750
0.24% 48
2025
Q1
$2.27M Hold
2,750
0.27% 47
2024
Q4
$2.12M Buy
2,750
+485
+21% +$402K 0.23% 49
2024
Q3
$2.01M Buy
+2,265
New +$2.04M 0.23% 50

Other funds holding LLY

Penn Davis McFarland's LLY Position: Q2 2026 in Review

Penn Davis McFarland held its Eli Lilly (LLY) position steady in Q2 2026 at 2,695 shares worth $3.23M. The position accounts for 0.29% of the portfolio, ranked #42.

Penn Davis McFarland first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Penn Davis McFarland held 2,695 shares of Eli Lilly worth $3.23M as of Q2 2026.
  • Penn Davis McFarland left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.29% of Penn Davis McFarland's portfolio in Q2 2026, its #42 holding.
  • Penn Davis McFarland first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Penn Davis McFarland's 13F filing for Q2 2026, filed 15 Jul 2026.